Danese, M., Sidelnikov, E., Villa, G., Catterick, D., Iqbal, M., Gleeson, M., et al. (2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. Bmj Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015
Toth, P. P., Danese, M., Villa, G., Qian, Y., Beaubrun, A., Lira, A., & Jansen, J. P. (2017). Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. J Med Econ. http://doi.org/10.1080/13696998.2017.1284078